1-(carboxymethylthio)tetradecane and ATLL

1-(carboxymethylthio)tetradecane has been researched along with ATLL in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Berge, RK; Drevon, CA; Gudbrandsen, OA; Iversen, PO; Rustan, AC; Sørensen, DR; Tronstad, KJ	1

Other Studies

1 other study(ies) available for 1-(carboxymethylthio)tetradecane and ATLL

Article	Year
A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-01, Volume: 12, Issue:11 Pt 1 Topics: Animals; Apoptosis; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Matrix Metalloproteinases; Neoplasm Metastasis; Rats; Structure-Activity Relationship; Sulfides; Survival Rate; Transplantation, Heterologous; Xenograft Model Antitumor Assays	2006

Article

Year

A bioactively modified fatty acid improves survival and impairs metastasis in preclinical models of acute leukemia.

Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jun-01, Volume: 12, Issue:11 Pt 1

Topics: Animals; Apoptosis; Diet; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Activation; Fatty Acids, Unsaturated; Humans; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Promyelocytic, Acute; Leukemic Infiltration; Matrix Metalloproteinases; Neoplasm Metastasis; Rats; Structure-Activity Relationship; Sulfides; Survival Rate; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2006